Industry News
Repeat Prostate Biopsies - PROGENSA® PCA3 Assay Helps Determine, Approved By FDA
Feb 17, 2012
On Wednesday, the US Food and Drug Administration (FDA) approved Gen-Probe's PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine whether men with a previous negative biopsy need a repeat biopsy... Read More
Fooling Cancer Cells With Nano-Technology
Feb 17, 2012
Survival rates of brain cancer continue to remain low, despite the substantial advances in detection, diagnosis, and treating tumors within the brian. This low survival rate is partly due to high levels of resistance to treatment... Read More
How Zygotes Sort Out Imprinted Genes
Feb 17, 2012
Writing in the February 17, 2012 issue of the journal Cell, researchers at the Ludwig Institute for Cancer Research, the University of California, San Diego School of Medicine and the Toronto Western Research Institute peel away some of the enduring mystery of how zygotes or fertilized eggs determine which copies of parental genes will be used or ignored... Read More
New Method Makes It Easier To Treat Prostate And Pancreatic Cancer
Feb 17, 2012
Laser light in combination with certain drugs - known as photodynamic therapy - can destroy cancer tumours, but is today used mostly to cure skin cancer. The reason that internal tumours are not treated with the method is that the technology does not exist to check that the precise amount of light is administered... Read More
Researchers Identify Cycle Of Platelet Production In Ovarian Cancer Patients
Feb 17, 2012
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine... Read More
Helping Patients Tackle Geographic Challenges To Access Clinical Trials
Feb 17, 2012
As oncologists already know and newly diagnosed lung cancer patients learn, the kind of treatment given to patients is increasingly becoming dependent on the specific gene mutation present in the cancer... Read More
Study Finds Female Cancer Survivors Have Worse Health Behaviors Than Women With No Cancer History
Feb 17, 2012
A recent study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and the Mayo Clinic in Rochester, Minn., has found that female cancer survivors receiving screening mammography have "worse health behaviors" than women receiving mammography screening and who had never had cancer. The study was published in a recent issue of the American Journal of Clinical Oncology... Read More
Survival In Medulloblastoma Model Extended By Oncolytic Virus
Feb 17, 2012
A strain of measles virus engineered to kill cancer cells prolongs survival in a model of medulloblastoma that is disseminated in the fluid around the brain, according to a new study by researchers at Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the Mayo Clinic... Read More
Therapeutic Cancer Vaccines Show Promise
Feb 17, 2012
Therapeutic cancer vaccines, which stimulate the body's immune system to target and destroy cancer cells, are being used in combination with conventional chemotherapy with growing success, as described in several illuminating articles in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc. These articles are available free online.(1) The U.S... Read More
In Malnourished Cancer Patients, Oral Nutritional Interventions Improve Nutritional Intake And QOL
Feb 17, 2012
Oral nutritional interventions help increase nutritional intake and improve some aspects of quality of life (QOL) in malnourished cancer patients or those who are at nutritional risk, but do not effect mortality, according to a study published in the Journal of the National Cancer Institute... Read More
Previous Page Next Page